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ABSTRACT 
Objectives: To decode the sequence of Epstein-barr virus (EBV) genome isolated from a pediatric patient with post transplant lymphoproliferative 
disorder (PTLD).  
Methods: EBV culture harvested from the blood sample of a 4-year-old patient with post liver transplant lymphoproliferative disorder prior to 
treatment was subjected to whole genome sequencing using Illumina platform. Generated data were subjected to various quality analysis and the 
filtered sequences were submitted to NCBI and published under accession number KM269735-KM269744. 
Results: Annotation results of VRF_ EBV01 genome using Prokka tool and manual blast search infers 48 hypothetical proteins, each 3 genes coding 
for Epstein-Barr nuclear antigen 3A and 3B and each one gene coding for Epstein-Barr nuclear antigens 1, 4, 4B and DNA primase UL70 protein. 
Single copy of genes coding for each variant of Tegument protein BSRF1, BLRF2, BGLF2 mir-BART 1,2,3,5,7,12,15,17,20 and two copies of gene 
coding for primary envelopment factor BFRF1 gene was also found. 
Conclusion: To date, only eight EBV genome sequences have been reported worldwide and there is no genome sequence reported from India. This 
study is the first of its kind to report on EBV genome from a post–transplant lymphoproliferative disorder to the scientific community for the 
welfare of research against EBV diagnostic markers and drug discovery. 
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Epstein-Barr virus (EBV) is a ubiquitous human gamma-herpes virus 
that infects more than 90% of the population worldwide. It has been 
implicated in the development of malignancies of lymphoid or 
epithelial origin, including B-cell lymphoma, T-cell lymphoma and B-
cell lymphoproliferations in immunocompromised patients [1], 
endemic Burkitt's lymphoma [2], Hodgkin's disease [3], 
undifferentiated nasopharyngeal carcinoma (NPC) [4], gastric 
carcinoma [5], Oral hairy leukoplakia in HIV patients [6]. 
To date there are eight EBV whole-genome sequences has been 
reported worldwide from various studies. A complete 171 kb wild-
type EBV reference genome, WT-EBV, (NCBI accession no: 
NC_007605.1/AJ507799.2) was later constructed using B95-8 [7] as 
a backbone while an 12 kb missing fragment in the EBV genome was 
provided by the EBV sequence found in Raji cells [8, 9]. Akata 
(KC207813) and Mutu (KC207814) genomes were reported recently 
from cases of Burkitt’s lymphomas from Japan and Kenya, 
respectively [10]
Human Umbilical cord blood mononuclear cells were isolated on 
Ficoll-Hypaque density gradients, further 10
. But there were no reports from India about the 
EBV genome, due to the complexity of the viral genome and 
insertion into the host genome making sequencing the data a 
difficult task [11-13]. This study provides the first draft genome 
analysis of EBV strain isolated from post transplant 
lymphoproliferative disorder (PTLD)-derived EBV strain 
VRF_EBV01. In the current study, Blood sample was collected from a 
4-year-old liver transplant patient with PTLD prior to treatment at the 
Global hospitals, Chennai, India. The patient's consent as well as 
approval from the Institute Research Ethics Committee was obtained. 
The serological titrations of immunoglobulin M antibodies against the 
EBV viral capsid antigen showed the presence of circulating antibody 
titre and real time PCR revealed 1,23,714 copies/ml of EBV.  
6 mononuclear 
Purified genomic DNA extracted by QIAamp DNA Mini Kit (Hilden, 
Germany) was then used to prepare a sequencing library using a 
Nextera DNA sample preparation kit (Illumina, San Diego, CA). 
Genome sequencing was performed at Scigenome, Bangalore, India 
using Illumina MiSeq version 2 systems. Generated Fastq files were 
validated, and filtered data was subjected to de novo assembly using 
CLC Genomics Workbench version 6.5[14]. Obtained result was 
subjected to Blast in NCBI and found to carrying viral genome with the 
host genome. Hence, viral genome was separated by mapping with 
reference genome EBV-B95-8 in CLC Genomics Workbench version 6.5 
and progressive alignments made using Mauve v2.3.1 with reference 
genome EBV-B95-8 resulted into 10 contigs [15]. Obtained viral 
genome was annotated using Prokka tool [16] and manual blast search 
with CLC Genomics Workbench version 6.5 and NCBI server. 
cells 
were infected for 2 h with EBV in 200 microlitres (µl) of the Buffy 
separated from the collected patient’s blood. After infection, the cells 
were washed with phosphate-buffered saline and then cultured in 
RPMI 1640 (plus 10% FBS and 0.5% pen/strep). The cultures were 
fed weekly with fresh medium. Small colonies began to appear 
within 35 to 50 days. Individual colonies were then expanded and 
maintained for DNA extraction.  
Annotation of VRF_EBV01 genome resulted in 48 hypothetical 
proteins in the total genome. The genome was comprised of 3 set of 
genes encoding for Epstein-Barr nuclear antigen 3A and 3B and each 
single gene sequences encoding for Epstein-Barr nuclear antigen 1, 4, 
4B and DNA primase UL70 protein. Single copy of genes encoding for 
each variant of Tegument protein BSRF1, BLRF2, BGLF2 and mir-
BART 1,2,3,5,7,12,15,17,20 and two copies of gene coding for primary 
envelopment factor BFRF1 revealed from the annotation study. 
Since, the available EBV genome sequences are scanty with different 
origins from all over the world comprised of host genome sequence. 
Report from this study will fetch into knowledge on EBV genome 
sequence from Indian origin, which may lead to better 
understanding of viral genome adaptation and lineation to its 
environment.  
Nucleotide sequence accession number 
The draft genome sequence of the Epstein Barr virus strain 
VRF_EBV01 is available in NCBI under the accession number 
KM269735-KM269744. 
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